Search your stocks

Share

Profile

SUNRESTSunrest Lifescience Ltd.

44.5(+0.45%)

1W: -13.56%

1M: -26.78%

1Y: +%

Financials

Pros & Cons

POSITIVES

Consistent revenue growth over the past three quarters indicates strong market demand.
Improved gross margins in the latest quarter reflect enhanced operational efficiency.
Recent investments in technology are likely to boost future production capabilities.

NEGATIVES

Declining net profit margins raise concerns about cost management.
Increasing raw material prices could pressure future profitability.
Recent fluctuations in demand may affect sales stability in upcoming quarters.

Quarterly Results Data

Field	Trend
Expenses	-
Operating Profit	-
Other Income	-
Tax	-